New treatment hope for kids with debilitating arthritis
NCT ID NCT00339157
Summary
This study tested whether anakinra could help children and young adults with severe systemic juvenile arthritis who weren't responding well to steroid treatments. For the first month, half received anakinra and half received a placebo, then all received anakinra for 11 more months while doctors tried to reduce their steroid doses. The main goal was to see if anakinra could significantly improve arthritis symptoms within one month and allow patients to use fewer steroids over a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bordeaux CHU
Bordeaux, 33000, France
-
Hopital Lyon Edouard Herriot
Lyon, 69437, France
-
Kremlin-Bicetre Hospital
Paris, 94270, France
-
Nancy Hopital d'Enfants
Nancy, 54511, France
-
Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants Malades Hospital, 149 rue de Sevres
Paris, 75015, France
-
Robert Debre Hospital
Paris, 75019, France
Conditions
Explore the condition pages connected to this study.